Vivos
OTC: RDGL
$0.06 ▲ +0.00  (+0.00%)
At close: Jul 23, 2026 · 4:00 PM UTC
Financial Ratios
Market Cap27.16 Mn
P/E-8.86
P/S397.25
Div. Yield0.00
Revenue Growth (1y) (Qtr)395.54
Add ratio to table…

About

Vivos Inc is a radiation oncology medical device company engaged in the development of its yttrium 90 based precision radionuclide therapy devices. The company creates RadioGel for human therapy and IsoPet for veterinary use. It also produces PLGA g PEG polymers and PrecisionGel a hydrogel platform for delivering active pharmaceutical ingredients. Vivos works with scientists engineers and strategic partners including national laboratories universities and private…

Read more ↓
Sector: Healthcare Industry: Medical Devices CIK: 0001449349

Product and Service Breakdown of Revenue (2025)

Peer Comparison

Companies in the Medical Devices
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 ABT Abbott Laboratories 201.40 Bn27.984.4634.05 Bn
2 SYK Stryker Corp 122.29 Bn36.604.8414.72 Bn
3 MDT Medtronic plc 105.01 Bn21.732.8927.96 Bn
4 BSX Boston Scientific Corp 64.81 Bn18.163.1411.03 Bn
5 EW Edwards Lifesciences Corp 55.28 Bn2,354.768.770.60 Bn
6 DXCM Dexcom Inc 29.06 Bn29.176.03-
7 PHG Koninklijke Philips Nv 29.02 Bn22.061.429.48 Bn
8 GEHC GE HealthCare Technologies Inc. 28.27 Bn14.301.3510.14 Bn